Stimate (desmopressin) Spray1 recalls
The FDA has published 1 recall involving Stimate (desmopressin) Spray1 since 2020. The latest was reported on 26 Aug 2020. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2020
Last 12 months0reported
Class I1100% of total
Ongoing0latest 26 Aug 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 100%Class II 0 0%Class III 0 0%
Why stimate (desmopressin) spray1 is recalled
Companies
By year
All stimate (desmopressin) spray1 recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Stimate (desmopressin acetate) Nasal Spray1.5 mg/mL glass recalled | Ferring Pharmaceuticals | Potency & Assay | Nationwide |
Should you stop taking Stimate (desmopressin) Spray1?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.